I like your tone...Butt,...FDA delays decision on Lillys Alzheimer drug....still feeling the burn on Adulheim...yet still doubling down on the Amyloid Plaque Factor.

Amyylyx's ALS Treatment Relyvrio FAILS PH111 study...thoughts about withdrawing drug.

Akero Therapeutics execs point to ADVANCED Fibrosis patients for MASH study...Madrigal is in the same lane...Still lots of room.

USS...When you're trying to beat the Devil...you have to go to Hell.